Product image of Xofigo (Radium Ra 223 Dichloride) supplied by GNH India

Xofigo

Active Ingredient:
Radium Ra 223 Dichloride
Origin:
EU

Xofigo (Radium Ra 223 Dichloride)

Xofigo (Radium Ra 223 Dichloride) is a radiopharmaceutical used to treat bone metastases in prostate cancer. Administered via intravenous infusion, it targets bone tissue to reduce pain and slow progression. Suitable for patients with symptomatic bone metastases. Short-term monitoring recommended after treatment.

Manufacturer / TM Owner

Bayer Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xofigo is used to treat bone metastases in patients with castration-resistant prostate cancer. It works by targeting areas of bone growth with targeted radiation, helping to relieve pain and slow the spread of cancer to bones. This treatment is typically considered when other therapies are no longer effective. Patients often seek options like Xofigo to manage symptoms and improve quality of life.

Side Effects

  • Xofigo is designed to reduce bone pain associated with metastases by delivering radiation directly to affected areas. Patients may experience temporary relief from discomfort and improved mobility. Common effects include mild fatigue and digestive changes, which are typically short-lived. Regular monitoring helps manage any side effects.

Precautions & Warnings

  • Xofigo should be handled by healthcare professionals in a controlled medical setting. Patients may need to avoid close contact with others for a short period after treatment to minimize radiation exposure. Hydration and frequent urination help reduce bladder exposure. Pregnant individuals should avoid handling Xofigo due to radiation risks.

Avoid Interactions

  • Xofigo may interact with other radiopharmaceuticals or chemotherapy agents, so concurrent treatments should be carefully coordinated. Patients undergoing external beam radiation therapy may need to pause Xofigo temporarily. Blood thinners and bone-strengthening medications may require adjustment during treatment. Always inform your healthcare provider about all medications being taken.

Frequently Asked Questions

Xofigo is used to treat bone metastases in patients with castration-resistant prostate cancer.

Xofigo is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects include fatigue, nausea, and digestive changes, which are usually temporary.

Xofigo may interact with other therapies, so treatment plans should be coordinated with a healthcare provider.

Xofigo is not suitable for pregnant individuals or those with certain medical conditions; consult a doctor for eligibility.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Radium Ra 223 Dichloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT